AI Image
Over 20,000 Bottles of Blood Pressure Medication Recalled Nationwide
EatingWell • • health
Key Points:
- The FDA has announced a nationwide voluntary recall of telmisartan and amlodipine blood pressure medications distributed by Mylan Pharmaceuticals due to a "superpotent drug" issue where telmisartan levels exceed specifications.
- The recall affects 30-count bottles in 40 mg (telmisartan) and 5 mg (amlodipine) doses, specifically lot numbers 3228113, 3228114, 3228115 (expiring Oct 31, 2026) and 3228120, 3228121 (expiring Nov 30, 2026), totaling over 21,000 bottles.
- This is a Class III recall, indicating the medication is unlikely to cause adverse health consequences, but patients are advised to stop use immediately if affected and consult their healthcare provider.
- Patients should check their prescriptions for the specified lot numbers and may return recalled medication to pharmacies for a refund.
- For further information, individuals can contact the FDA at 1-888-INFO-FDA (1-888-463-6332).
